Suitability depends on the condition, cell type, plans permitted under Korean law, and an individual assessment. The EHL team reviews your health information and explains the available options before confirming a care plan.
The public EHL BIO website is organised into cell technology sections covering stem cells, immune cells and stem cell conditioned media; a disease topic section named CURE that includes Alzheimer's disease, degenerative arthritis, diabetes, erectile dysfunction, cirrhosis, myocardial infarction, COPD, autoimmune disease and atopic dermatitis; an R&D section with the GMP centre and a list of patents and research papers; and hospital information with contact channels. Importantly, the CURE section presents disease topics the hospital and its research centre study — it is not a list of treatments approved in Thailand. Interested readers should check the legal status in their own country and check the evidence level for each disease in trial registries and academic journals.
Source: EHL BIO — English website
Related disease topics
Experts behind this content
EHL Thailand Medical Information Team — Evidence levels, regulatory status, and separating hospital information from medical information
EHL BIO scientific information is compiled alongside public information from its research team and GMP centre. See the full expert panel